Stock SVS SVAS BIOSANA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Svas Biosana S.p.A.

Equities

SVS

IT0005469264

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-04-26 am EDT 		5-day change 1st Jan Change
8.25 EUR +0.61% Intraday chart for Svas Biosana S.p.A. +2.48% +3.12%
Apr. 16 Svas Biosana increases profit in 2023; ex-dividend proposed AN
Apr. 15 Mib bullish; Leonardo on top AN

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 86.8 54.58 44.54 44.54 -
Enterprise Value (EV) 1 103.8 76.24 71.64 71.94 69.84
P/E ratio 38.8 x - 9.48 x 7.3 x 6.45 x
Yield - - - - -
Capitalization / Revenue 1.07 x 0.56 x 0.38 x 0.36 x 0.34 x
EV / Revenue 1.28 x 0.78 x 0.61 x 0.58 x 0.54 x
EV / EBITDA 9.75 x 6.41 x 4.71 x 4.33 x 3.92 x
EV / FCF -30.7 x 40.1 x -13.3 x -180 x 33.3 x
FCF Yield -3.26% 2.49% -7.54% -0.56% 3.01%
Price to Book - - - - -
Nbr of stocks (in thousands) 5,600 5,569 5,398 5,398 -
Reference price 2 15.50 9.800 8.250 8.250 8.250
Announcement Date 4/14/22 4/14/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 76 81.09 97.23 118.2 123.5 129.5
EBITDA 1 - 10.65 11.9 15.2 16.6 17.8
EBIT 1 - 5.771 6.257 8.8 10.1 11.2
Operating Margin - 7.12% 6.44% 7.45% 8.18% 8.65%
Earnings before Tax (EBT) - - - - - -
Net income 1 2.514 3.161 3.571 4.9 6.3 7.1
Net margin 3.31% 3.9% 3.67% 4.15% 5.1% 5.48%
EPS 2 - 0.4000 - 0.8700 1.130 1.280
Free Cash Flow 1 - -3.381 1.899 -5.4 -0.4 2.1
FCF margin - -4.17% 1.95% -4.57% -0.32% 1.62%
FCF Conversion (EBITDA) - - 15.96% - - 11.8%
FCF Conversion (Net income) - - 53.17% - - 29.58%
Dividend per Share - - - - - -
Announcement Date 3/9/22 4/14/22 4/14/23 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - 17 21.7 27.1 27.4 25.3
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - 1.598 x 1.821 x 1.783 x 1.651 x 1.421 x
Free Cash Flow 1 - -3.38 1.9 -5.4 -0.4 2.1
ROE (net income / shareholders' equity) - 8.03% 6.77% 8.2% 9.7% 9.8%
ROA (Net income/ Total Assets) - 2.59% 2.53% 2.8% 3.5% 3.8%
Assets 1 - 122 141.1 175 180 186.8
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - 5.92 2.99 5.3 9.1 9.1
Capex / Sales - 7.3% 3.07% 4.48% 7.37% 7.03%
Announcement Date 3/9/22 4/14/22 4/14/23 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Svas Biosana S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.25 EUR
Average target price
14.2 EUR
Spread / Average Target
+72.12%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SVAS BIOSANA S.P.A. Stock Svas Biosana S.p.A.
+3.12% 47.54M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SVS Stock
  4. Financials Svas Biosana S.p.A.